DS

David S.

Chief Financial Officer at Oramed Pharmaceuticals

David S. has a diverse work experience spanning over many years. David is currently working as the Chief Financial Officer at Oramed Pharmaceuticals Inc. Since joining the company in June 2021, they have been responsible for financial management. Prior to this role, David served as the Chief Internal Auditor at The Bloomfield Science Museum Jerusalem from January 2020 to June 2021.

David's previous experience includes working at Teva Pharmaceuticals, where they held multiple roles. David served as the FP&A Team Leader from April 2018 to June 2021, and before that, they worked as the Finance Senior Manager, Global Internal Audit from September 2014 to April 2018.

Before joining Teva Pharmaceuticals, David was a Member of the Audit Committee at Gvahim from November 2010 to May 2019. David gained valuable experience as a Manager in the Business Risk Services department at Grant Thornton LLP from August 2009 to September 2014.

David began their career as an Auditor at KPMG US in January 2009. Prior to that, they worked as an Auditor at AGC Conseils from 2007 to 2008. In 2006, David co-founded Tseyirim and served as the Treasurer.

Overall, David S. has a strong background in both finance and audit, with extensive experience in various leadership roles.

David S. completed their education in the field of accounting and finance. David obtained a Bachelor's Degree in Accounting and Finance from ENOES - French Ministry of Higher Education and Research, which they attended from 2004 to 2008. David further pursued a Master's Degree in Accounting, Audit, Law, Finance Economics, and Tax from the same institution, from 2008 to 2009. In addition to their academic qualifications, David S. holds a certification as a Certified Public Accountant (CPA) from the Institute of Certified Public Accountants in Israel. The specific details regarding the month and year of obtaining this certification are not provided.

Links

Timeline

  • Chief Financial Officer

    June, 2021 - present

View in org chart